These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3686653)

  • 1. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay.
    Nance SJ; Arndt P; Garratty G
    Transfusion; 1987; 27(6):449-52. PubMed ID: 3686653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
    Arndt PA; Garratty G
    Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monocyte monolayer assay, an
    Nance SJT
    Immunohematology; 2023 Jun; 39(2):61-69. PubMed ID: 37405851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes.
    Branch DR; Gallagher MT; Mison AP; Sy Siok Hian AL; Petz LD
    Br J Haematol; 1984 Jan; 56(1):19-29. PubMed ID: 6704325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemiluminescence test for predicting the outcome of transfusing incompatible blood.
    Hadley A; Wilkes A; Poole J; Arndt P; Garratty G
    Transfus Med; 1999 Dec; 9(4):337-42. PubMed ID: 10583888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay.
    Kipkeu BJ; Shyian ML; da Silveira Cavalcante L; Duong TT; Yeung RSM; Binnington B; Branch DR; Acker JP; Holovati JL
    Transfusion; 2018 Aug; 58(8):2027-2035. PubMed ID: 29744883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Monocyte Monolayer Assay: Past, Present and Future.
    Tong TN; Cen S; Branch DR
    Transfus Med Rev; 2019 Jan; 33(1):24-28. PubMed ID: 30139679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients.
    Fabron A; Baleotti W; de Mello AB; Chiba AK; Kuwano S; Figueiredo MS; Bordin JO
    Transfus Apher Sci; 2004 Aug; 31(1):29-35. PubMed ID: 15294192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
    Garratty G
    Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells.
    Boligan KF; Sandhu G; Branch DR
    Curr Protoc; 2022 Aug; 2(8):e504. PubMed ID: 35926124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta.
    Eckrich RJ; Mallory DM; Sandler SG
    Immunohematology; 1995; 11(3):81-4. PubMed ID: 15447064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte monolayer assay (MMA) reactivity of alloantibodies reacting by the manual polybrene technique but not by an antiglobulin test.
    Lown J; Willis J
    Transfus Med; 1995 Dec; 5(4):281-4. PubMed ID: 8646292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal conditions for the performance of a monocyte monolayer assay.
    Tong TN; Burke-Murphy E; Sakac D; Pendergrast J; Cserti-Gazdewich C; Laroche V; Branch DR
    Transfusion; 2016 Nov; 56(11):2680-2690. PubMed ID: 27546234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction.
    Hunt JS; Beck ML; Hardman JT; Tegtmeier GE; Bayer WL
    Am J Clin Pathol; 1980 Sep; 74(3):259-64. PubMed ID: 7416078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units.
    Baldwin ML; Ness PM; Barrasso C; Kickler TS; Drew H; Tsan MF; Shirey RS
    Transfusion; 1985; 25(1):34-8. PubMed ID: 3969699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell survival studies in a patient with anti-Tca.
    Anderson G; Gray LS; Mintz PD
    Am J Clin Pathol; 1991 Jan; 95(1):87-90. PubMed ID: 1987756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay.
    Conrado MCAV; D'Avila AN; Vieira JB; Bonifacio SL; Gomes FCA; Dezan MR; Oliveira VB; Ribeiro IH; Tucunduva LTCM; Mendrone-Júnior A; Rocha V; Dinardo CL
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28568311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte monolayer assay in pre-transfusion testing: A magic key in transfusing patients with recurrent bad cross-match due to alloimmunization.
    El-Sayed HAN; Abdollah MRA; Raafat SN; Ragab D
    J Immunol Methods; 2021 May; 492():112968. PubMed ID: 33465386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.